{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:01:05Z","timestamp":1787241665426,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T00:00:00Z","timestamp":1722729600000},"content-version":"vor","delay-in-days":216,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BBA Advances"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.bbadva.2024.100119","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:01:15Z","timestamp":1723154475000},"page":"100119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["4-Phenyl-thiazole-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase do not alleviate orofacial inflammatory pain in female rats"],"prefix":"10.1016","volume":"6","author":[{"given":"Daniel","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Chacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monijeh Khoja","family":"Herawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Morisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevan","family":"Pecic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3254-2341","authenticated-orcid":false,"given":"Ram","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbadva.2024.100119_bib0001","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.bbadva.2024.100119_bib0002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/14740338.2021.1965988","article-title":"Gastrointestinal and cardiovascular adverse events associated with NSAIDs","volume":"21","author":"Domper Arnal","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.bbadva.2024.100119_bib0003","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/can.2021.0237","article-title":"Fatty acid amide hydrolase: an integrative clinical perspective","volume":"8","author":"Santoso","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"issue":"3","key":"10.1016\/j.bbadva.2024.100119_bib0004","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s13311-020-00916-4","article-title":"Soluble epoxide hydrolase regulation of lipid mediators limits pain","volume":"17","author":"Wagner","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbadva.2024.100119_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105157","article-title":"Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine","volume":"147","author":"Greco","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.bbadva.2024.100119_bib0006","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","article-title":"Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models","volume":"147","author":"Jayamanne","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbadva.2024.100119_bib0007","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-008-9075-y","article-title":"Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation","volume":"11","author":"Schlosburg","year":"2009","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.bbadva.2024.100119_bib0008","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.jmedchem.0c01886","article-title":"Movement to the clinic of soluble epoxide hydrolase inhibitor EC5026 as an analgesic for neuropathic pain and for use as a nonaddictive opioid alternative","volume":"64","author":"Hammock","year":"2021","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bbadva.2024.100119_bib0009","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.drudis.2015.07.017","article-title":"A multimodal disease modifying approach to treat neuropathic pain\u2013inhibition of soluble epoxide hydrolase (sEH)","volume":"20","author":"Pillarisetti","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbadva.2024.100119_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phrs.2015.04.001","article-title":"Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive","volume":"97","author":"Sasso","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadva.2024.100119_bib0011","article-title":"Structure-activity relationship studies of benzothiazole-phenyl analogs as multi-target ligands to alleviate pain without affecting normal behavior","volume":"164","author":"Angelia","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbadva.2024.100119_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116507","article-title":"Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase\/fatty acid amide hydrolase inhibitors","volume":"51","author":"Wilt","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbadva.2024.100119_bib0013","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ab.2006.10.041","article-title":"Development of highly sensitive fluorescent assays for fatty acid amide hydrolase","volume":"363","author":"Huang","year":"2007","journal-title":"Anal.. Biochem"},{"issue":"5","key":"10.1016\/j.bbadva.2024.100119_bib0014","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/cbdd.13670","article-title":"Design, microwave-assisted synthesis, biological evaluation and molecular modeling studies of 4-phenylthiazoles as potent fatty acid amide hydrolase inhibitors","volume":"95","author":"Wilt","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.bbadva.2024.100119_bib0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ab.2005.03.041","article-title":"Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies","volume":"343","author":"Jones","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbadva.2024.100119_bib0016","doi-asserted-by":"crossref","first-page":"891","DOI":"10.12688\/f1000research.18338.1","article-title":"A refinement to the formalin test in mice","volume":"8","author":"Lopes","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.bbadva.2024.100119_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104165","article-title":"Development of multitarget inhibitors for the treatment of pain: design, synthesis, biological evaluation and molecular modeling studies","volume":"103","author":"Wilt","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bbadva.2024.100119_bib0018","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s10194-017-0721-6","article-title":"Depression of home cage wheel running: a reliable and clinically relevant method to assess migraine pain in rats","volume":"18","author":"Kandasamy","year":"2017","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.bbadva.2024.100119_bib0019","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","article-title":"Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases","volume":"180","author":"Wagner","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadva.2024.100119_bib0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbr.2017.01.054","article-title":"FAAH inhibition produces antidepressant-like efforts of mice to acute stress via synaptic long-term depression","volume":"324","author":"Wang","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.bbadva.2024.100119_bib0021","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bbadva.2024.100119_bib0022","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.bmcl.2018.01.003","article-title":"Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase","volume":"28","author":"Kodani","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bbadva.2024.100119_bib0023","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neubiorev.2003.12.003","article-title":"The orofacial formalin test","volume":"28","author":"Raboisson","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.bbadva.2024.100119_bib0024","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0304-3940(89)90125-0","article-title":"Application of the formalin test to the study of orofacial pain in the rat","volume":"103","author":"Clavelou","year":"1989","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.bbadva.2024.100119_bib0025","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/j.1440-1681.2009.05179.x","article-title":"Formalin-induced increase in P2X(3) receptor expression in dorsal root ganglia: implications for nociception","volume":"36","author":"Pan","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"12","key":"10.1016\/j.bbadva.2024.100119_bib0026","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jpain.2006.04.010","article-title":"The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception","volume":"7","author":"Luccarini","year":"2006","journal-title":"J. Pain"},{"issue":"35","key":"10.1016\/j.bbadva.2024.100119_bib0027","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1523\/JNEUROSCI.2663-18.2019","article-title":"Differences between dorsal root and trigeminal ganglion nociceptors in mice revealed by translational profiling","volume":"39","author":"Megat","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadva.2024.100119_bib0028","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fnmol.2017.00304","article-title":"The molecular fingerprint of dorsal root and trigeminal ganglion neurons","volume":"10","author":"Lopes","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.bbadva.2024.100119_bib0029","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1213\/ANE.0000000000000640","article-title":"The effects of levetiracetam, sumatriptan, and caffeine in a rat model of trigeminal pain: interactions in 2-component combinations","volume":"120","author":"Tomic","year":"2015","journal-title":"Anesth. Analg."},{"issue":"7","key":"10.1016\/j.bbadva.2024.100119_bib0030","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ddr.21819","article-title":"Beyond its anti-migraine properties, sumatriptan is an anti-inflammatory agent: a systematic review","volume":"82","author":"Ala","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bbadva.2024.100119_bib0031","article-title":"Anti-inflammatory effects of epoxyeicosatrienoic acids","volume":"2012","author":"Thomson","year":"2012","journal-title":"Int. J. Vasc. Med."}],"container-title":["BBA Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667160324000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667160324000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T11:16:50Z","timestamp":1734175010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667160324000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":31,"alternative-id":["S2667160324000073"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadva.2024.100119","relation":{},"ISSN":["2667-1603"],"issn-type":[{"value":"2667-1603","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Phenyl-thiazole-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase do not alleviate orofacial inflammatory pain in female rats","name":"articletitle","label":"Article Title"},{"value":"BBA Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadva.2024.100119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100119"}}